Milton S. Hershey Medical Center
Clinical trials sponsored by Milton S. Hershey Medical Center, explained in plain language.
Upcoming readouts
Trials from this sponsor expected to report results within the next 12 months.
- Virtual reality headsets bring peace to ICU patients Results expected Sep 2026 (estimated)
- Can a quick daily workout beat standard group classes for seniors with mobility issues? Results expected Sep 2026 (estimated)
- Yoga vs. endometriosis pain: new study tests a Drug-Free approach Results expected Sep 2026 (estimated)
- Can facing fears help treat anorexia? new study tests exposure therapy Results expected Sep 2026 (estimated)
- Survivor stories aim to boost HPV shots in kids Results expected Oct 2026 (estimated)
-
Baby shampoo and mouthwash may fight COVID-19, study finds
Disease control Stopped earlyThis study tested whether using a baby shampoo nasal wash and Listerine mouthwash for 4 days could lower the amount of COVID-19 virus in the nose and throat of recently infected adults aged 18-65. Participants were randomly assigned to different wash combinations, including plain…
Phase 2/3 • Sponsor: Milton S. Hershey Medical Center • Aim: Disease control
Last updated Sep 16, 2026 00:00 UTC
-
Promising cream for painful skin condition tested in tiny trial
Disease control Stopped earlyThis small, early trial tested a cream called ruxolitinib 1.5% on 6 people with early-stage hidradenitis suppurativa, a painful skin condition that causes lumps and abscesses. The goal was to see if the cream could reduce inflammation and improve symptoms after 16 weeks. However,…
Phase 2 • Sponsor: Milton S. Hershey Medical Center • Aim: Disease control
Last updated Jun 27, 2026 12:24 UTC
-
Chemo cocktail aimed at zapping pancreatic cysts
Disease control Stopped earlyThis study tested whether injecting chemotherapy drugs directly into pancreatic cysts could shrink or eliminate them. It involved 75 adults with cysts between 2-5 cm. The approach used an endoscope to guide the injection, comparing two different pre-treatment rinses. The trial wa…
Phase 3 • Sponsor: Milton S. Hershey Medical Center • Aim: Disease control
Last updated Jun 27, 2026 12:02 UTC
-
Could a common antifungal pill fight brain tumors?
Knowledge-focused Stopped earlyThis early-phase trial tested whether posaconazole, a drug used for fungal infections, can reach brain tumors in high enough amounts to stop cancer cells from dividing. Seven adults with glioblastoma took the drug before surgery, and researchers measured drug levels in their spin…
Early phase 1 • Sponsor: Milton S. Hershey Medical Center • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:13 UTC
-
Antifungal drug tested against brain cancer — but trial stops early
Knowledge-focused Stopped earlyThis early-phase trial tested whether ketoconazole, a drug normally used for fungal infections, can enter brain tumors in high enough amounts to stop tumor cells from dividing. Only 1 person was enrolled before the study was terminated. The goal was to measure drug levels in the …
Early phase 1 • Sponsor: Milton S. Hershey Medical Center • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:08 UTC